Chemoinformaics analysis of 14-Acetoxygelsenicine
Molecular Weight | 384.432 | nRot | 3 |
Heavy Atom Molecular Weight | 360.24 | nRig | 25 |
Exact Molecular Weight | 384.169 | nRing | 6 |
Solubility: LogS | -4.333 | nHRing | 4 |
Solubility: LogP | 2.394 | No. of Aliphatic Rings | 5 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 4 |
No. of Heavy Atom | 28 | No. of Aromatic Carbocycles | 1 |
nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 4 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 2 |
No. of Carbon atom | 21 | No. of Saturated Rings | 3 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
No. of Oxygen atom | 5 | No. of Arom Bond | 6 |
nHA | 6 | APOL | 57.283 |
nHD | 0 | BPOL | 32.731 |
QED | 0.746 |
Synth | 6.314 |
Natural Product Likeliness | 2.385 |
NR-PPAR-gamma | 0.007 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.998 |
Pgp-sub | 0.003 |
HIA | 0.011 |
CACO-2 | -4.97 |
MDCK | 0.0000482 |
BBB | 0.983 |
PPB | 0.385802 |
VDSS | 0.85 |
FU | 0.470939 |
CYP1A2-inh | 0.018 |
CYP1A2-sub | 0.522 |
CYP2c19-inh | 0.044 |
CYP2c19-sub | 0.937 |
CYP2c9-inh | 0.036 |
CYP2c9-sub | 0.093 |
CYP2d6-inh | 0.015 |
CYP2d6-sub | 0.14 |
CYP3a4-inh | 0.428 |
CYP3a4-sub | 0.902 |
CL | 5.925 |
T12 | 0.041 |
hERG | 0.027 |
Ames | 0.747 |
ROA | 0.906 |
SkinSen | 0.037 |
Carcinogencity | 0.858 |
EI | 0.012 |
Respiratory | 0.769 |
NR-Aromatase | 0.947 |
Antiviral | No |
Prediction | 0.560359 |